title: [Gemcitabine treatment of pancreatic cancer peritonitis].
authors.affiliation: Division of Internal Medicine, St. Luke's International Hospital, Division of Gastroenterology, National Mie Chuo Hospital, 3rd Department of Internal Medicine, Mie University.
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Horiki
authors.forename: Masataka
authors.initials: M
authors.lastname: Maruyama
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Fujita
authors.forename: Yuko
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Tanaka
authors.forename: Makoto
authors.initials: M
authors.lastname: Shimomura
authors.forename: Kanji
authors.initials: K
authors.lastname: Tanigawa
authors.forename: Hidehito
authors.initials: H
authors.lastname: Sasaki
authors.forename: Mieko
authors.initials: M
authors.lastname: Fujiwara
authors.forename: Kouyou
authors.initials: K
authors.lastname: Suzuki
authors.forename: Ichiro
authors.initials: I
authors.lastname: Imoto
authors.forename: Yukihiko
authors.initials: Y
authors.lastname: Adachi
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy*; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010190:Pancreatic Neoplasms / Q000150:complications / Q000188:drug therapy*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine